This means that over the past quarter there has been an increase of insiders selling their shares ... and marketing of an insulin infusion system for people with insulin-dependent diabetes. It ...

Wells Fargo analyst Larry Biegelsen assigned a Buy rating to Insulet (PODD – Research Report) today and set a price target of $290.00.

Beta Bionics has launched the integration of its flagship iLet Bionic Pancreas with Abbott’s FreeStyle Libre 3 Plus sensor.

Managing stress and maintaining overall health can be quite challenging in today’s fast-paced world. Many people turn to ...

IRVINE, CA / ACCESSWIRE / October 30, 2024 / Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes ...

Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ETCompany ParticipantsLarry Heaton – Chief Executive OfficerMike ...

Beta Bionics announced today that it launched the integration of the iLet bionic pancreas with the Abbott (NYSE:ABT) ...

Kenanga Research, however, expects Pharmaniaga to make a recovery and post earnings at a level before Covid, driven by regular orders for medical supplies ... has managed to sell some,” the ...

AdaptHealth Corp. (NASDAQ:AHCO – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the six ...

Some patients, with or without the help of doctors, are experimenting with “microdosing” weight loss drugs — using ...

AdaptHealth (NASDAQ:AHCO – Free Report) had its target price reduced by Robert W. Baird from $16.00 to $14.00 in a report ...

Shreya Life Sciences, a very little-known pharmaceutical company based in Mumbai, India, has surfaced as an unexpected player ...